pancrelipase lipase, pancrelipase protease, pancrelipase amylase
pancrelipase lipase, pancrelipase protease, pancrelipase amylase is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including Zenpep. Available dosage form: capsule, delayed release.
Drug Details
- Generic Name
- pancrelipase lipase, pancrelipase protease, pancrelipase amylase
- Brand Names
- Zenpep
- Application Number
- BLA022210
- Sponsor
- Aimmune Therapeutics, Inc.
- NDC Codes
- 8
- Dosage Forms
- CAPSULE, DELAYED RELEASE
- Routes
- ORAL
- Active Ingredients
- PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE
Indications and Usage
1 INDICATIONS AND USAGE ZENPEP ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients. ZENPEP ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients. ( 1 )